BARCLAYS PLC - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 80 filers reported holding SPERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
204
-94.8%
0.00%
Q1 2022$35,000
-96.3%
3,930
-93.3%
0.00%
Q4 2021$940,000
+413.7%
58,742
+489.5%
0.00%
Q3 2021$183,000
+137.7%
9,965
+79.1%
0.00%
Q2 2021$77,000
-75.9%
5,564
-74.3%
0.00%
Q1 2021$319,000
+145.4%
21,640
+223.0%
0.00%
Q4 2020$130,000
+35.4%
6,700
-21.7%
0.00%
Q3 2020$96,000
-26.2%
8,558
-11.9%
0.00%
Q2 2020$130,000
+282.4%
9,709
+124.7%
0.00%
Q1 2020$34,000
-68.8%
4,320
-62.0%
0.00%
Q4 2019$109,000
+87.9%
11,361
+106.3%
0.00%
Q3 2019$58,000
-25.6%
5,508
-18.9%
0.00%
Q2 2019$78,000
+136.4%
6,789
+164.5%
0.00%
Q1 2019$33,000
+1550.0%
2,567
+488.8%
0.00%
Q4 2018$2,000
-94.6%
436
-87.7%
0.00%
Q3 2018$37,000
+428.6%
3,557
+628.9%
0.00%
Q2 2018$7,000
-63.2%
488
-62.2%
0.00%
Q1 2018$19,000
+72.7%
1,291
+35.0%
0.00%
Q4 2017$11,0009560.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,353,303$1,637,49713.93%
Anson Funds Management LP 4,159,572$5,033,0821.01%
OUP Management Co., LLC 249,070$301,3750.68%
Atlas Venture Life Science Advisors, LLC 1,013,438$1,226,2600.19%
Murchinson Ltd. 862,700$1,043,8670.13%
Alphabet Inc. 889,979$1,076,8740.07%
AWM Investment Company, Inc. 333,400$403,4140.06%
DAFNA Capital Management LLC 125,000$151,2500.05%
Novo Holdings A/S 468,902$567,3710.04%
XTX Topco Ltd 58,368$70,6250.01%
View complete list of SPERO THERAPEUTICS INC shareholders